Latest Headlines

  1. High Barrier Pharma Packaging Needed For Quality Meds, Experts Say
    4/17/2014

    Improved anti-counterfeit features and high barrier packaging are needed to maintain quality and protect molecule sensitivity of various drugs, experts said in a seminar held in Mumbai recently.

     

  2. Pharma Execs Respond To DSCSA
    4/17/2014

    Frequentz announced the release of the company-sponsored 2014 RxTrace 'US Pharma Traceability Survey'. The survey reveals the pharmaceutical industry’s perspectives on the Drug Supply Chain Security Act (DSCSA).

  3. FDA Clears Breathe Tech’s NIOV System For Respiratory Insufficiency
    4/17/2014

    Breathe Technologies announced that the U.S. Food and Drug Administration (FDA) has granted 501(k) clearance for its Non-Invasive Open Ventilation (NIOV) System for use with compressed air supply.

     

  4. EMA Warns Of Stolen And Tampered Herceptin Vials
    4/17/2014

    The European Medicines Agency has alerted healthcare professionals in the EU after identifying falsified Herceptin (trastuzumab) vials. Herceptin is Roche’s breast cancer drug containing the active drug trastuzumab.

  5. Small Indian Pharma Contract Producers Face Fierce Competition
    4/17/2014

    The decreasing number of small and medium pharmaceutical enterprises may lead to a disproportionate price increase in drugs, warns a small scale pharma industry association in India.

  6. Thomson Reuters Forecasts Leading Drugs To Watch For In 2014
    4/16/2014

    The Intellectual Property & Science business of Thomson Reuters has released its annual forecast of leading drugs to watch for in 2014.

  7. Critical Pharma Begins Phase 1 Trial Of Nano-Enabled Osteoporosis Drug
    4/16/2014

    Critical Pharmaceuticals with collaborators The University of Nottingham and Nottingham University Hospitals NHS Trust announced the initiation of the first Phase I trial for a nano-enabled intranasal teriparatide product. The product will be evaluated for the treatment of osteoporosis in post-menopausal women.

  8. Domestic Prices Of Bulk Drugs From India Likely To Increase This Year
    4/16/2014

    The growth of bulk drugs exported from India has slowed in recent months, due to regulatory questions from the U.S. and the EU. However, the price of bulk drugs is expected to increase in India this year.

  9. GP-CC Urges Pharma Companies To Form Coalition Against Chinese Counterfeit Drugs
    4/15/2014

    The Global Piracy and Counterfeiting Consultants (GP-CC) offered its assistance to the U.S. Postal Service to stop delivery of Chinese counterfeit pharmaceutical products through U.S. mail. The group also urged U.S. consumers to be wary of purchasing pharmaceutical items online.

  10. FDA Clears GE Healthcare’s Revolution CT Scanner
    4/15/2014

    General Electric Company unit GE Healthcare announced the U.S. Food and Drug Administration’s 510(k) clearance of Revolution CT, which converges best capabilities of spatial resolution, temporal resolution, and whole organ coverage in one CT scanner.